Algiax Pharmaceuticals develops products for nervous system disease or dysfunction with a strong focus on neuropathic pain.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Erkrath
State: Nordrhein-Westfalen
Zip:
Country: Germany
Algiax Pharmaceuticals GmbH is an independent biotechnology company that was established in April 2011. It is dedicated to the discovery and development of innovative products in the field of nervous system disease or dysfunction with a strong focus on neuropathic pain. The company is financially stable having raised 4,3 million Euro’s in Series A financing from a consortium of private and state-backed investors.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2012 | Series A | 2 | $5.5M |
High-Tech Grunderfonds KfW High-Tech Grunderfonds KfW |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|